James K. Nelson
Affiliations: | Truven Health Analytics |
Area:
Cognitive Neuroscience, Attention, Cognition, Cognitive Control, Conceptual Learning, Scientific Thinking; Healthcare outcomesGoogle:
"James Nelson"Bio:
Dartmouth College, Education (2006-2009)
Adelphi University, Psychology (2009-2012)
Truven Health Analytics (2013- )
Mean distance: 15.51 (cluster 15) | S | N | B | C | P |
Parents
Sign in to add mentorMarlene Behrmann | research assistant | 1995-1998 | Carnegie Mellon | |
Patricia A. Reuter-Lorenz | grad student | 1998-2005 | University of Michigan | |
(Interference resolution in the left inferior frontal gyrus.) | ||||
Kevin N. Dunbar | post-doc | 2006-2007 |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Johnston S, Cappell K, Nelson J, et al. (2016) FUNCTIONAL FORM OF THE RELATIONSHIP BETWEEN ADHERENCE TO GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST THERAPY AND MEDICAL HEALTH CARE COSTS AMONG PATIENTS WITH TYPE 2 DIABETES IN THE UNITED STATES Value in Health. 19: A205 |
Johnston SS, Nguyen H, Cappell K, et al. (2015) Retrospective study comparing healthcare costs and utilization between commercially insured patients with type 2 diabetes mellitus who are newly initiating exenatide once weekly or liraglutide in the United States. Journal of Medical Economics. 1-12 |
Johnston S, Nguyen H, Felber E, et al. (2015) Adhärenz gegenüber Therapie mit GLP-1 Rezeptoragonisten bei Patienten mit Typ 2 Diabetes mellitus Diabetologie Und Stoffwechsel. 10 |
Johnston S, Nguyen H, Cappell K, et al. (2015) Adherence to Liraglutide once daily or exenatide once weekly Over A 12-Month period among Commercially Insured Patients With Type 2 diabetes Mellitus: A retrospective observational study Value in Health. 18: A64 |
Johnston SS, Nguyen H, Felber E, et al. (2014) Retrospective study of adherence to glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus in the United States. Advances in Therapy. 31: 1119-33 |
Johnston S, Nguyen H, Felber E, et al. (2014) Medication use and treatment patterns of glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes mellitus Value in Health. 17: A261-A262 |
Johnston S, Nguyen H, Felber E, et al. (2014) Health care costs among type 2 diabetes mellitus patients initiating glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy Value in Health. 17: A244 |
Gmeindl L, Nelson JK, Wiggin T, et al. (2011) Configural representations in spatial working memory: modulation by perceptual segregation and voluntary attention. Attention, Perception & Psychophysics. 73: 2130-42 |
Cimprich B, Reuter-Lorenz P, Nelson J, et al. (2010) Prechemotherapy alterations in brain function in women with breast cancer. Journal of Clinical and Experimental Neuropsychology. 32: 324-31 |
Nelson JK, Reuter-Lorenz PA, Persson J, et al. (2009) Mapping interference resolution across task domains: a shared control process in left inferior frontal gyrus. Brain Research. 1256: 92-100 |